Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vlad Ratziu

Showing results (41-50 of 384) with videos related to

Pageof 39
Sort By:
Clinics in Liver Disease|November 27, 2013
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver diseaseRaluca Pais, Elena Rusu, Vlad Ratziu
Journal of Hepatology|February 8, 2011
FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpretedMona Munteanu, Vlad Ratziu, Thierry Poynard
Gastroenterology|November 28, 2002
Discussion on celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failureVlad Ratziu, Maya Nourani, Thierry Poynard
Journal of Hepatology|May 19, 2022
Breakthroughs in therapies for NASH and remaining challengesVlad Ratziu, Sven Francque, Arun Sanyal
Journal of Hepatology|January 16, 2021
Yet more evidence that MAFLD is more than a name changeMohammed Eslam, Vlad Ratziu, Jacob George
The American Journal of Gastroenterology|October 8, 2011
The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis testMona Munteanu, Vlad Ratziu, Thierry Poynard
Annals of Internal Medicine|September 13, 2013
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infectionThierry Poynard, Vlad Ratziu, Mona Munteanu
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Non-alcoholic fatty liver disease: diagnosis and investigationFabio Nascimbeni, Paola Loria, Vlad Ratziu
Journal of Hepatology|August 31, 2011
Touching some firm ground in the epidemiology of NASHVlad Ratziu, Mihai Voiculescu, Thierry Poynard
Therapeutic Advances in Gastroenterology|September 17, 2011
Glitazones for human nonalcoholic steatohepatitisRaluca Pais, Ioana Moraru, Vlad Ratziu
Pageof 39

Showing results (41-50 of 384) with videos related to

Sort By:
Pageof 39
Clinics in Liver Disease|November 27, 2013
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver diseaseRaluca Pais, Elena Rusu, Vlad Ratziu
Journal of Hepatology|February 8, 2011
FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpretedMona Munteanu, Vlad Ratziu, Thierry Poynard
Gastroenterology|November 28, 2002
Discussion on celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failureVlad Ratziu, Maya Nourani, Thierry Poynard
Journal of Hepatology|May 19, 2022
Breakthroughs in therapies for NASH and remaining challengesVlad Ratziu, Sven Francque, Arun Sanyal
Journal of Hepatology|January 16, 2021
Yet more evidence that MAFLD is more than a name changeMohammed Eslam, Vlad Ratziu, Jacob George
The American Journal of Gastroenterology|October 8, 2011
The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis testMona Munteanu, Vlad Ratziu, Thierry Poynard
Annals of Internal Medicine|September 13, 2013
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infectionThierry Poynard, Vlad Ratziu, Mona Munteanu
Digestive Diseases (Basel, Switzerland)|July 19, 2014
Non-alcoholic fatty liver disease: diagnosis and investigationFabio Nascimbeni, Paola Loria, Vlad Ratziu
Journal of Hepatology|August 31, 2011
Touching some firm ground in the epidemiology of NASHVlad Ratziu, Mihai Voiculescu, Thierry Poynard
Therapeutic Advances in Gastroenterology|September 17, 2011
Glitazones for human nonalcoholic steatohepatitisRaluca Pais, Ioana Moraru, Vlad Ratziu
Pageof 39